Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
Sign Up to like & getrecommendations! Published in 2020 at "Marine Drugs"
DOI: 10.3390/md18090438
Abstract: Parkinson’s disease (PD), characterized by dopaminergic neuron degeneration in the substantia nigra and dopamine depletion in the striatum, affects up to 1% of the global population over 50 years of age. Our previous study found… read more here.
Keywords: glucuronomannan oligosaccharides; preparation neuroprotective; parkinson; activity glucuronomannan ... See more keywords